Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InTec is a private in vitro diagnostics company focused on infectious disease screening and point-of-care testing. Founded in 1989 and based in Xiamen, China, the company develops, manufactures, and exports rapid diagnostic tests, ELISA kits, blood grouping products, and self-tests for decentralized healthcare settings. Its portfolio includes commercial products for HIV, HCV, HBV, malaria, syphilis, COVID-19, monkeypox, typhoid, and ABO/RhD blood grouping. InTec emphasizes affordable, scalable diagnostics for public-health programs and has obtained certifications and listings including CE, WHO prequalification for selected products, GMP, ISO 9001, and ISO 13485. The company appears to operate as a diagnostics/product company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InTec Products.